Weis Markets Q2 profit falls as pharmacy pricing headwinds weigh
WMK•Quarterly results
- US food retailer's Q2 revenue rose 4.6% yr/yr, comparable store sales up 2.3%
- Q2 net income declined 9.6% yr/yr, EPS fell to $0.92 from $0.96
- Pharmacy revenue growth was hurt by Inflation Reduction Act Medicare pricing headwinds
| Metric | Beat/Miss | Actual | Consensus Estimate |
| Q2 Sales | $1.28 bln | ||
| Q2 EPS | $0.92 | ||
| Q2 Net Income | $22.86 mln |
Additional context
Company press release: ID:nPnb3sg7ra
Outlook and sales drivers
-
Company says customers remain focused on affordability and value, impacting shopping behavior
-
Weis Markets is increasing investment in promotions and targeted loyalty marketing
-
PROMOTIONS AND LOYALTY MARKETING - Co said increased investment in promotions and targeted loyalty marketing supported sales growth
-
PHARMACY PRICING PRESSURE - Co said pharmacy revenue growth was hurt by Medicare pricing headwinds from the Inflation Reduction Act
